Clinical efficacy and cost/benefit ratio of current treatment of MRSA infections in intensive care units
Abstract
THE RISK FACTORS FOR BACTERIAL RESISTANCE: These are recent history of hospitalization and/or antibiotics, notably levofloxacine or macrolides, an increase in severity of the disease, prolonged hospitalization in intensive care before the diagnosis and the existence of decubitus bed sores. THE IMPACT OF MRSA INFECTIONS: Is clinical to start, with a greater mortality rate in MRSA bacteremias than in staphylococcal sensitive, in vancomycin-resistant enterococcal infections than in enterococcal sensitive infections, and in acquired pneumonia under mechanical ventilation. From an economical point of view, the progression in bacterial resistances in intensive care units has consequences not only on the patients and the hospital but also on the whole of society. TO FIGHT AGAINST NOSOCOMIAL INFECTIONS: Three measures should be taken: means of prevention must be used, appropriate antibiotic treatments must be administered early and days of hospitalization must be reduced.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.